We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLX icon
1201
Deluxe
DLX
$1.15B
$208K 0.03%
12,498
-5,142
-29% -$108K
MCO icon
1202
Moody's
MCO
$82.7B
$208K 0.03%
+854
New +$248K
NOVT icon
1203
Novanta
NOVT
$6.29B
$208K 0.03%
+1,799
New +$245K
SP
1204
DELISTED
SP Plus Corporation
SP
$208K 0.03%
+6,652
New +$220K
SNPS icon
1205
Synopsys
SNPS
$79.7B
$207K 0.03%
+678
New +$230K
TNC icon
1206
Tennant Co
TNC
$1.26B
$207K 0.03%
+3,658
New +$229K
VMW
1207
DELISTED
VMware, Inc
VMW
$207K 0.03%
1,947
-1,657
-46% -$191K
BOOM icon
1208
DMC Global
BOOM
$157M
$206K 0.03%
+12,891
New +$262K
SPG icon
1209
Simon Property Group
SPG
$72.3B
$206K 0.03%
2,298
-4,471
-66% -$457K
COR icon
1210
Cencora
COR
$61.2B
$205K 0.03%
1,513
-128
-8% -$18.4K
HOPE icon
1211
Hope Bancorp
HOPE
$1.79B
$205K 0.03%
16,201
+5,635
+53% +$81.5K
OTLK icon
1212
Outlook Therapeutics
OTLK
$191M
$205K 0.03%
8,391
+140
+2% +$3.25K
WTFC icon
1213
Wintrust Financial
WTFC
$10.7B
$205K 0.03%
2,513
-7,774
-76% -$660K
MRNS
1214
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$205K 0.03%
30,856
-11,400
-27% -$70.2K
ABEV icon
1215
Ambev
ABEV
$46.4B
$204K 0.03%
+72,136
New +$205K
ADPT icon
1216
Adaptive Biotechnologies
ADPT
$3.97B
$204K 0.03%
28,702
+4,457
+18% +$42K
DIN icon
1217
Dine Brands
DIN
$452M
$204K 0.03%
+3,206
New +$223K
LEGH icon
1218
Legacy Housing
LEGH
$694M
$204K 0.03%
+11,922
New +$189K
GTN icon
1219
Gray Television
GTN
$552M
$203K 0.03%
+14,173
New +$260K
ADSK icon
1220
Autodesk
ADSK
$52.6B
$202K 0.03%
1,081
-440
-29% -$88.9K
CRI icon
1221
Carter's
CRI
$1.47B
$202K 0.03%
3,087
-3,190
-51% -$244K
PRCH icon
1222
Porch Group
PRCH
$1.8B
$202K 0.03%
89,876
+48,390
+117% +$117K
TK icon
1223
Teekay
TK
$985M
$202K 0.03%
+56,157
New +$187K
VRA icon
1224
Vera Bradley
VRA
$98.7M
$202K 0.03%
66,946
+38,340
+134% +$154K
HIW icon
1225
Highwoods Properties
HIW
$3.47B
$201K 0.03%
7,471
-11,968
-62% -$387K

Similar funds

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.